Delivery Order SPE2DB20D2014-SPE2DB25FC95B
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,033.28 to AmerisourceBergen Drug Corp for the supply of Premarin Vaginal Cream in 30-gram applicators. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Premarin Vaginal Cream in 30-gram applicator units, with a ceiling value of $1,647.94. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,032.81 to AmerisourceBergen Drug Corp for Premarin Vaginal Cream in 30-gram applicator units. This firm fixed-price contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive, non-set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the same...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Premarin Vaginal Cream in 30 gram applications. The contract has a completion date of March 1, 2024 and a potential value of $1,662.72. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,375.75 to AmerisourceBergen Drug Corp for Premarin Vaginal Cream (30 grams) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Premarin Vaginal Cream in 30-gram applications, with a contract value of $2,174.86 and an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through...
- The Defense Logistics Agency awarded a delivery order valued at $3,592.04 to AmerisourceBergen Drug Corp for Premarin Vaginal Cream (30-gram applicator) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $3,556.91 to AmerisourceBergen Drug Corp for Premarin Vaginal Cream (30-gram applicator) on September 8, 2025, with completion expected by September 9, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,342.15 to AmerisourceBergen Drug Corp for Premarin Vaginal Cream (30gm) under a firm fixed price contract. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location in the same city. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of Premarin Vaginal Cream. The contract has a ceiling value of $1,688.67 and runs through May 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC95BDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Premarin Vaginal Cream in 30-gram applications, with a ceiling value of $2,347.68. The contract, which was competitively awarded without a set-aside designation, carries a firm fixed price structure and an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's comprehensive federal contract portfolio encompasses a broad range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for hormone treatment medication aligns with the company's established role within the DLA's global pharmaceutical supply chain, supporting the Defense Health Agency and other government healthcare systems. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen among the key suppliers for these strategic federal medical supply initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/9/25 |